Drug Type ASO |
Synonyms- |
Target- |
Mechanism- |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic dysfunction-associated steatotic liver disease | Discovery | KR | ![]() | 12 Jun 2024 |
Obesity | Discovery | KR | ![]() | 12 Jun 2024 |
Parkinson Disease | Discovery | KR | ![]() | - |